ClinConnect ClinConnect Logo
Search / Trial NCT06544876

Balance Control and Recovery in Diabetes Peripheral Neuropathy

Launched by LISA GRIFFIN · Aug 5, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Diabetic Peripheral Neuropathy Balance Sensation Aging Older Adult Foot Sit To Stand Falls Falling

ClinConnect Summary

This clinical trial is studying how diabetic peripheral neuropathy, a condition that affects nerves in people with diabetes, impacts balance control and muscle activity in adults over the age of 50. The researchers want to understand how well participants can maintain their balance and how quickly they can recover from losing their balance when standing still. This is important because good balance is key to preventing falls and injuries.

To participate in this study, you need to be at least 50 years old and have Type II diabetes along with peripheral neuropathy, which means you experience nerve damage due to diabetes. Unfortunately, if you have certain conditions like foot ulcers, partial amputations, a history of stroke, or painful neuropathy, you won't be eligible. During the trial, participants will complete tasks like standing up from a seated position and responding to balance challenges. This research could help improve our understanding of balance issues in older adults with diabetes, leading to better care and support.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Type II diabetes with peripheral neuropathy
  • Exclusion Criteria:
  • Foot ulcer
  • Partial amputation
  • Have experience of Stroke
  • Painful neuropathy
  • Inability to stand or walk independently

About Lisa Griffin

Lisa Griffin is a dedicated clinical trial sponsor with extensive experience in the pharmaceutical and biotechnology sectors. Committed to advancing medical research, she oversees the design, implementation, and management of clinical trials aimed at developing innovative therapies. With a strong focus on ethical practices and regulatory compliance, Lisa collaborates with multidisciplinary teams to ensure the highest standards of patient safety and data integrity. Her leadership is characterized by a passion for improving health outcomes and a commitment to fostering collaboration between researchers, healthcare professionals, and regulatory bodies.

Locations

Austin, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported